Can ovarian tuberculosis (TB) metastasize to the liver?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Yes, ovarian tuberculosis can metastasize to the liver, though this is not common. Tuberculosis primarily affects the lungs but can spread to other organs through the bloodstream or lymphatic system in a process called extrapulmonary tuberculosis. When TB affects the ovaries, it can potentially disseminate to other organs including the liver, especially in cases of advanced or untreated disease. The spread occurs because Mycobacterium tuberculosis bacteria can travel through the bloodstream from the primary infection site to establish secondary infection sites in organs with high blood flow and oxygen content, such as the liver. Some studies have reported cases of ovarian metastasis from other primary sites, including the stomach, breast, and pancreas, with a lower percentage of metastasis from the liver 1. However, the exact mechanism and frequency of ovarian tuberculosis metastasizing to the liver are not well-studied. In general, treatment for disseminated TB requires a standard anti-tuberculosis regimen, and in cases with liver involvement, liver function tests should be monitored regularly during treatment 2, 3, 4, 5. Patients with compromised immune systems, particularly those with HIV/AIDS, are at higher risk for such disseminated disease. It is essential to note that while the provided studies discuss hepatotoxicity associated with anti-tuberculosis therapy, they do not directly address the metastasis of ovarian tuberculosis to the liver. Therefore, the management of ovarian tuberculosis should prioritize standard anti-tuberculosis treatment and monitoring for potential liver involvement. Key points to consider in the management of ovarian tuberculosis include:

  • Standard anti-tuberculosis regimen consisting of isoniazid, rifampin, ethambutol, and pyrazinamide
  • Monitoring of liver function tests in cases with liver involvement
  • Potential for hepatotoxicity associated with anti-tuberculosis therapy
  • Higher risk of disseminated disease in patients with compromised immune systems.

References

Research

Clinical implications of metastases to the ovary.

Gynecologic oncology, 1995

Research

Antituberculous therapy-induced fulminant hepatic failure: successful treatment with liver transplantation and nonstandard antituberculous therapy.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2006

Research

Safety and completion rate of short-course therapy for treatment of latent tuberculosis infection.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.